November 21, 2024

CDC Warns: COVID, RSV Spike Ahead

Reuters

November 21, 2024

Dr. Martin Makary May Be Trump's FDA Pick

Dr. Makary has served as an adviser to Washington conservative health care think tank Paragon Health Institute.

Reuters

November 21, 2024

How New Drugs Are Shaping UC Guidelines

The AGA now suggests early use of advanced therapies rather than gradual step-up with 5-ASAs in moderate-to-severe UC, emphasizing this approach in its latest recommendations.

Conexiant

November 21, 2024

ASCP Urges Trump Team to Rescind FDA Lab Rule

The organization expressed concerns that the Rule would impose duplicative oversight requirements on clinical laboratories.

Conexiant

November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

Conexiant

November 19, 2024

Gantenerumab Linked to ARIA Risk in Early Alzheimer's Disease

86% of ARIA-E cases occurred within the first 64 weeks of gantenerumab treatment, with APOE ε4 homozygotes showing nearly 5-fold increased risk.

Conexiant

November 19, 2024

MASLD Affects 42% of US Adults, Study Finds

A US-based study found Hispanic individuals had significantly higher metabolic dysfunction-associated steatotic liver disease prevalence at 47.0% compared to 40.7% in non-Hispanic whites, despite nearly half of all U.S. adults showing signs of fatty liver disease.

Conexiant

November 19, 2024

Novel Stroke Drug Shows 12-Hour Window

Despite a median treatment time of 9.5 hours after stroke onset - more than twice the current therapeutic window - JX10 showed significantly better functional outcomes than placebo with no symptomatic intracranial hemorrhage events.

Conexiant

November 19, 2024

Can Fluid Restriction Stop MDMA Hyponatremia?

A 433% oxytocin increase—not vasopressin—correlated with MDMA-induced hyponatremia, with fluid restriction preventing all cases in a controlled setting.

Conexiant